Cap Partners, LLC Abb Vie Inc. Transaction History

Cap Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $4,024 - $4,699	-26 Reduced 1.16%	2,206 $378 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $958 - $1,092	-6 Reduced 0.27%	2,232 $406 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $307,948 - $346,822	2,238 New	2,238 $347 Million

3,783

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cap Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cap Partners, LLC with notifications on news.